BLFS
BIOLIFE SOLUTIONS INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$36.69
−0.43%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.01
- Revenue estimate
- $29.2M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.91
- EPS estimate
- $0.03
- Revenue actual
- $28.5M
- Revenue estimate
- $27.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +447.1%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $31
- PT range
- $31 – $31
- Analysts
- 6
0 Buy6 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.03 | $0.91 | Beat 2812.00% | $28.5M |
| May 7, 2026 | $0.01 | $0.04 | Beat 300.00% | $27.5M |
| Aug 7, 2025 | -$0.02 | -$0.33 | Miss -1556.75% | $25.4M |
| May 8, 2025 | -$0.03 | $0.04 | Beat 233.33% | $23.9M |
| Mar 3, 2025 | -$0.06 | -$0.01 | Beat 83.33% | $3.4M |
| Aug 8, 2024 | -$0.14 | -$0.06 | Beat 57.14% | $28.3M |
| May 9, 2024 | -$0.26 | -$0.19 | Beat 26.92% | $31.7M |
| Feb 29, 2024 | -$0.36 | -$0.30 | Beat 16.67% | $32.7M |
| Nov 9, 2023 | -$0.38 | -$0.67 | Miss -76.32% | $33.3M |
| Mar 16, 2023 | -$0.19 | -$1.15 | Miss -505.26% | $44.3M |
| Nov 9, 2022 | -$0.18 | -$0.23 | Miss -27.78% | $40.7M |
| Aug 9, 2022 | -$0.20 | -$1.71 | Miss -755.00% | $40.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026